Choroidal thinning as a new finding in Alzheimer's Disease: Evidence from enhanced depth imaging spectral domain optical coherence tomography

Journal of Alzheimer's Disease

Volumn 40, Issue 4, 2014, Pages 907-917

  Gharbiya, Magda ^a   Trebbastoni, Alessandro ^a   Parisi, Francesco ^a   Manganiello, Silvia ^a   Cruciani, Filippo ^a   D'Antonio, Fabrizia ^a   De Vico, Umberto ^a   Imbriano, Letizia ^a   Campanelli, Alessandra ^a   De Lena, Carlo ^a  

^a POLICLINICO UMBERTO I   (Italy)

Author keywords

Age related macular degeneration; Alzheimer's disease; biomarker; choroid; choroidal thickness; enhanced depth imaging; optical coherence tomography; peripapillary RNFL thickness; retinal thickness; SD OCT

Indexed keywords

AGED; ALZHEIMER DISEASE; ALZHEIMER DISEASE ASSESSMENT SCALE; ARTICLE; CENTRAL RETINAL THICKNESS; CHOROID; CHOROIDAL THICKNESS; CLINICAL ARTICLE; CLINICAL DEMENTIA RATING; CONTROLLED STUDY; CORNEA CURVATURE; CROSS-SECTIONAL STUDY; DIABETIC RETINOPATHY; ENHANCED DEPTH IMAGING; EYE EXAMINATION; FEMALE; HUMAN; IMAGING; INTRAOCULAR PRESSURE; MALE; MINI MENTAL STATE EXAMINATION; OCULOPLETHYSMOGRAPHY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RETINA MACULA AGE RELATED DEGENERATION; RETINAL NERVE FIBER LAYER THICKNESS; SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY; VISUAL ACUITY; VISUAL SYSTEM PARAMETERS; MIDDLE AGED; OPTICAL COHERENCE TOMOGRAPHY; PATHOLOGY; RETINA; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; CHOROID; FEMALE; HUMANS; MALE; MIDDLE AGED; RETINA; TOMOGRAPHY, OPTICAL COHERENCE;

EID: 84901770743     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-132039     Document Type: Article

References (61)

1. Thal LJ, Kantarci K, Reiman EM, Klunk WE, Weiner MW, Zetterberg H, Galasko D, Praticò D, Griffin S, Schenk D, Siemers E (2006) The role of biomarkers in clinical trials for Alzheimer disease. Alzheimer Dis Assoc Disord 20, 6-15.
2. Guo L, Duggan J, Cordeiro MF (2010) Alzheimer's disease and retinal neurodegeneration. Curr Alzheimer Res 7, 3-14.
3. Hinton DR, Sadun AA, Blanks JC, Miller CA (1986) Opticnerve degeneration in Alzheimer's disease. N Engl J Med 315, 485-487.
4. Blanks JC, Hinton DR, Sadun AA, Miller CA (1989) Retinal ganglion cell degeneration in Alzheimer's disease. Brain Res 501, 364-372.
5. Sadun AA, Bassi CJ (1990) Optic nerve damage in Alzheimer's disease. Ophthalmology 97, 9-17.
6. Blanks JC, Torigoe Y, Hinton DR, Blanks RH (1996) Retinal pathology in Alzheimer's disease. I. Ganglion cell loss in foveal/parafoveal retina. Neurobiol Aging 17, 377-384.
7. Blanks JC, Schmidt SY, Torigoe Y, Porrello KV, Hinton DR, Blanks RH (1996) Retinal pathology in Alzheimer's disease. II. Regional neuron loss and glial changes in GCL. Neurobiol Aging 17, 385-395.
8. Curcio CA, Drucker DN (1993) Retinal ganglion cells in Alzheimer's disease and aging. Ann Neurol 33, 248-257.
9. Davies DC, McCoubrie P, McDonald B, Jobst KA (1995) Myelinated axon number in the optic nerve is unaffected by Alzheimer's disease. Br J Ophthalmol 79, 596-600.
10. Kirbas S, Turkyilmaz K, Anlar O, Tufekci A, Durmus M (2013) Retinal nerve fiber layer thickness in patients with Alzheimer disease. J Neuroophthalmol 33, 58-61.
11. Moreno-Ramos T, Benito-Léon J, Villarejo A, Bermejo- Pareja F (2013) Retinal nerve fiber layer thinning in dementia associated with Parkinson's disease, dementia with lewy bodies, and Alzheimer's disease. J Alzheimers Dis 34, 659-664.
12. Moschos MM, Markopoulos I, Chatziralli I, Rouvas A, Papageorgiou SG, Ladas I, Vassilopoulos D (2012) Structural and functional impairment of the retina and optic nerve in Alzheimer's disease. Curr Alzheimer Res 9, 782-788.
13. Kesler A, Vakhapova V, Korczyn AD, Naftaliev E, Neudorfer M (2011) Retinal thickness in patients with mild cognitive impairment and Alzheimer's disease. Clin Neurol Neurosurg 113, 523-526.
14. Lu Y, Li Z, Zhang X, Ming B, Jia J, Wang R, Ma D (2010) Retinal nerve fiber layer structure abnormalities in early Alzheimer's disease: Evidence in optical coherence tomography. Neurosci Lett 480, 69-72.
15. Paquet C, Boissonnot M, Roger F, Dighiero P, Gil R, Hugon J (2007) Abnormal retinal thickness in patients with mild cognitive impairment and Alzheimer's disease. Neurosci Lett 420, 97-99.
16. Berisha F, Feke GT, Trempe CL, McMeel JW, Schepens CL (2007) Retinal abnormalities in early Alzheimer's disease. Invest Ophthalmol Vis Sci 48, 2285-2289.
17. Iseri PK, Altinaş O, Tokay T, Yüksel N (2006) Relationship between cognitive impairment and retinal morphological and visual functional abnormalities in Alzheimer disease. J Neuroophthalmol 26, 18-24.
18. Parisi V, Restuccia R, Fattapposta F, Mina C, Bucci MG, Pierelli F (2001) Morphological and functional retinal impairment in Alzheimer's disease patients. Clin Neurophysiol 112, 1860-1867.
19. Danesh-Meyer HV, Birch H, Ku JY, Caroll S, Gamble G (2006) Reduction of optic nerve fibers in patients with Alzheimer disease identified by laser imaging. Neurology 67, 1852-1854.
20. Kergoat H, Kergoat MJ, Justino L, Chertkow H, Robillard A, Bergman H (2001) An evaluation of the retinal nerve fiber layer thickness by scanning laser polarimetry in individuals with dementia of the Alzheimer type. Acta Ophthalmol Scand 79, 187-191.
21. Frost S, Kanagasingam Y, Sohrabi H, Vignarajan J, Bourgeat P, Salvado O, Villemagne V, Rowe CC, Macaulay SL, Szoeke C, Ellis KA, Ames D, Masters CL, Rainey-Smith S, Martins RN, AIBL Research Group (2013) Retinal vascular biomarkers for early detection and monitoring of Alzheimer's disease. Transl Psychiatry 3, e233.
22. de laTorre JC (2002) Alzheimer disease as a vascular disorder: Nosological evidence. Stroke 33, 1152-1162.
23. Bell RD, Zlokovic BV (2009) Neurovascular mechanisms and blood-brain barrier disorder in Alzheimer's disease. Acta Neuropathol 118, 103-113.
24. Nickla DL, Wallman J (2010) The multifunctional choroid. Prog Retin Eye Res 29, 144-168.
25. Zarbin MA (2004) Current concepts in the pathogenesis of age-related macular degeneration. Arch Ophthalmol 122, 598-614.
26. Hayreh SS (1969) Blood supply of the optic nerve head and its role in optic atrophy, glaucoma, and oedema of the optic disc. Br J Ophthalmol 53, 721-748.
27. Sivak JM(2013) The aging eye: Common degenerative mechanisms between the Alzheimer's brain and retinal disease. Invest Ophthalmol Vis Sci 54, 871-880.
28. Margolis R, Spaide RF (2009) A pilot study of enhanced depth imaging optical coherence tomography of the choroid in normal eyes. Am J Ophthalmol 147, 811-815.
29. Maruko I, Iida T, Sugano Y, Ojima A, Sekiryu T (2011) Subfoveal choroidal thickness in fellow eyes of patients with central serous chorioretinopathy. Retina 31, 1603-1608.
30. Fujiwara T, Imamura Y, Margolis R, Slakter JS, Spaide RF (2009) Enhanced depth imaging optical coherence tomography of the choroid in highly myopic eyes. Am J Ophthalmol 148, 445-450.
31. ManjunathV, Goren J, Fujimoto JG, Duker JS (2011) Analysis of choroidal thickness in age-related macular degeneration using spectral-domain optical coherence tomography. Am J Ophthalmol 152, 663-668.
32. Ko A, Cao S, Pakzad-Vaezi K, Brasher PM, Merkur AB, Albiani DA, Kirker AW, Cui J, Matsubara J, Forooghian F (2013) Optical coherence tomography-based correlation between choroidal thickness and drusen load in dry agerelated macular degeneration. Retina 33, 1005-1010.
33. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDAWork Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34, 939-944.
34. Burton EJ, Barber R, Mukaetova-Ladinska EB, Robson J, Perry RH, Jaros E, Kalaria RN, O'Brien JT (2009) Medial temporal lobe atrophy on MRI differentiates Alzheimer's disease from dementia with Lewy bodies and vascular cognitive impairment: A prospective study with pathological verification of diagnosis. Brain 132, 195-203.
35. Fazekas F, Chawluk JB, Alavi A, Hurtig HI, Zimmerman RA (1987) MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging. AJR Am J Roentgenol 149, 351-356.
36. Román GC, Tatemichi TK, Erkinjuntti T, Cummings JL, Masdeu JC, Garcia JH, Amaducci L, Orgogozo JM, Brun A, Hofman A, Moody DM, O'Brien MD, Yamaguchi T, Grafman J, Drayer BP, Bennett DA, Fisher M, Ogata J, Kokmen E, Bermejo F, Wolf PA, Gorelick PB, Bick KL, Pajeau AK, Bell MA, DeCarli C, Culebras A, Korczyn AD, Bogousslavsky J, Hartmann A, Scheinberg P (1993) Vascular dementia: Diagnostic criteria for research studies. Report of the NINDSAIREN International Workshop. Neurology 43, 250-260.
37. Johnson NA, Jahng GH, Weiner MW, Miller BL, Chui HC, Jagust WJ, Gorno-Tempini ML, Schuff N (2005) Pattern of cerebral hypoperfusion in Alzheimer disease and mild cognitive impairment measured with arterial spin-labeling MR imaging: Initial experience. Radiology 234, 851-859.
38. Jellinger KA (2002) Alzheimer disease and cerebrovascular pathology: An update. J Neural Transm 109, 813-836.
39. Farkas E, LuitenPG(2001) Cerebral microvascular pathology in aging and Alzheimer's disease. Prog Neurobiol 64, 575-611.
40. Suo Z, Humphrey J, Kundtz A, Sethi F, Placzek A, Crawford F, MullanM(1998) Soluble Alzheimers beta-amyloid constricts the cerebral vasculature in vivo. Neurosci Lett 257, 77-80.
41. Bailey TL, Rivara CB, Rocher AB, Hof PR (2004) The nature and effects of cortical microvascular pathology in aging and Alzheimer's disease. Neurol Res 26, 573-578.
42. Grammas P, Yamada M, Zlokovic B (2002) The cerebromicrovasculature: A key player in the pathogenesis of Alzheimer's disease. J Alzheimers Dis 4, 217-223.
43. Kalaria RN, Pax AB (1995) Increased collagen content of cerebral microvessels in Alzheimer's disease. Brain Res 705, 349-352.
44. Thal DR, Griffin WS, de Vos RA, Ghebremedhin E (2008) Cerebral amyloid angiopathy and its relationship to Alzheimer's disease. Acta Neuropathol 115, 599-609.
45. Liu B, Rasool S, Yang Z, Glabe CG, Schreiber SS, Ge J, Tan Z (2009) Amyloid-peptide vaccinations reduce beta-amyloid plaques but exacerbate vascular deposition and inflammation in the retina of Alzheimer's transgenic mice. Am J Pathol 175, 2099-2110.
46. Busch S, Wu L, Feng Y, Gretz N, Hoffmann S, Hammes HP (2012) Alzheimer's disease and retinal neurodegeneration share a consistent stress response of the neurovascular unit. Cell Physiol Biochem 30, 1436-1443.
47. Hoh Kam J, Lenassi E, Jeffery G (2010) Viewing ageing eyes: Diverse sites of amyloid beta accumulation in the ageing mouse retina and the up-regulation of macrophages. PLoS One 5, pii: e13127.
48. Ning A, Cui J, To E, Ashe KH, Matsubara J (2008) Amyloidbeta deposits lead to retinal degeneration in a mouse model of Alzheimer disease. Invest Ophthalmol Vis Sci 49, 5136-5143.
49. Miao J, Xu F, Davis J, Otte-Höller I, Verbeek MM, Van NostrandWE( 2005) Cerebral microvascular amyloid beta protein deposition induces vascular degeneration and neuroinflammation in transgenic mice expressing human vasculotropic mutant amyloid beta precursor protein. Am J Pathol 167, 505-515.
50. MarchesiVT(2011) Alzheimer's dementia begins as a disease of small blood vessels, damaged by oxidative-induced inflammation and dysregulated amyloid metabolism: Implications for early detection and therapy. FASEB J 25, 5-13.
51. Johnson LV, Leitner WP, Rivest AJ, Staples MK, Radeke MJ, Anderson DH (2002) The Alzheimer's A beta-peptide is deposited at sites of complement activation in pathologic deposits associated with aging and age-related macular degeneration. Proc Natl Acad Sci U S A 99, 11830-11835.
52. Mullins RF, Johnson MN, Faidley EA, Skeie JM, Huang J (2011) Choriocapillaris vascular dropout related to density of drusen in human eyes with early age-related macular degeneration. Invest Ophthalmol Vis Sci 52, 1606-1612.
53. Dentchev T, Milam AH, Lee VM, Trojanowski JQ, Dunaief JL (2003) Amyloid-beta is found in drusen from some agerelated macular degeneration retinas, but not in drusen from normal retinas. Mol Vis 9, 184-190.
54. Ohno-Matsui K (2011) Parallel findings in age-related macular degeneration and Alzheimer's disease. Prog Retin Eye Res 30, 217-238.
55. Anderson DH, Mullins RF, Hageman GS, Johnson LV (2002) A role for local inflammation in the formation of drusen in the aging eye. Am J Ophthalmol 134, 411-431.
56. Liu RT, Gao J, Cao S, Sandhu N, Cui JZ, Chou CL, Fang E, Matsubara JA (2013) Inflammatory mediators induced by amyloid-beta in the retina and RPE in vivo: Implications for inflammasome activation in age-related macular degeneration. Invest Ophthalmol Vis Sci 54, 2225-2237.
57. Marziani E, Pomati S, Ramolfo P, Cigada M, Giani A, Mariani C, Staurenghi G (2013) Evaluation of retinal nerve fiber layer and ganglion cell layer thickness in Alzheimer's diseaseusing spectral-domain optical coherence tomography. Invest Ophthalmol Vis Sci 54, 5953-5958.
58. Wang YX, Pan Z, Zhao L, You QS, Xu L, Jonas JB (2013) Retinal nerve fiber layer thickness. The beijing eye study 2011. PLoS One 8, e66763.
59. Cheung CY, Chen D, Wong TY, Tham YC, Wu R, Zheng Y, Cheng CY, Saw SM, Baskaran M, Leung CK, Aung T (2011) Determinants of quantitative optic nerve measurements using spectral domain optical coherence tomography in a population-based sample of non-glaucomatous subjects. Invest Ophthalmol Vis Sci 52, 9629-9635.
60. Savini G, Barboni P, Parisi V, CarbonelliM(2012) The influence of axial length on retinal nerve fibre layer thickness and optic-disc size measurements by spectral-domain OCT. Br J Ophthalmol 96, 57-61.
61. Zarei M, Damoiseaux JS, Morgese C, Beckmann CF, Smith SM, Matthews PM, Scheltens P, Rombouts SA, Barkhof F (2009) Regional white matter integrity differentiates between vascular dementia and Alzheimer disease. Stroke 40, 773-779.